Search images on Google Product Monograph
Active Ingredients:
- insulin glargine, 300 UNIT/ML
DIN: 02441829
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: 1.5ML (450 IU) PREFILLED PEN
Schedule: Schedule D
Company: SANOFI-AVENTIS CANADA INC – official site
ATC:
- A10 - DRUGS USED IN DIABETES (ATC, WHO, Wiki)
- A10A - INSULINS AND ANALOGUES (ATC, WHO)
- A10AE - Insulins and analogues for injection, long-acting (ATC, WHO)
- A10AE04 - INSULIN GLARGINE (WHO)
Reference brand drug: Lantus
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 3X1.5ML/ 5X1.5ML
External Links for Toujeo Solostar:
Search on Google
- Toujeo Solostar side effects
- Toujeo Solostar dosage
- insulin glargine side effects
- insulin glargine dosage
Sanofi-Aventis Canada Inc
Go to Sanofi-Aventis website to see drug product details. Sometimes you can find toujeo solostar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.